We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Monthly results for the REACT-1 study of coronavirus transmission.
Safety leaflet on topical corticosteroids and withdrawal reactions to help patients and their carers to use these medicines safely.
How marketing authorisation holders should inform MHRA of a signal or an ADR to a medicine.
Who you should contact if a pet or other animal or human has a reaction to a veterinary medicine or a problem with a microchip.
Change your protocol, update your authorisation, report safety issues, submit safety updates and complete your end-of-trial study report.
The characteristics, symptoms, diagnosis and treatment of alpha-gal syndrome.
Results of real-time assessment of community transmission – prevalence of coronavirus (COVID-19) antibodies in 2020.
Syri Limited, T/A SyriMed is recalling batches of product as a precautionary measure due to crystallisation observed over time in the oral solution.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).